Literature DB >> 4724998

Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. IV. Dysplasia and carcinoma in situ.

E Adam, R H Kaufman, J L Melnick, A H Levy, W E Rawls.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4724998     DOI： 10.1093/oxfordjournals.aje.a121541

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  13 in total

1.  Preparation and efficacy of an inactivated subunit vaccine (NFUIBHK) against type 2 Herpes simplex virus infection.

Authors:  G R Skinner; D R Williams; A Buchan; J Whitney; M Harding; K Bodfish
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

2.  Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a "hit and run" mechanism.

Authors:  G R Skinner
Journal:  Br J Exp Pathol       Date:  1976-08

3.  Augmentation of the neutralisation test for type 1 HSV: evidence of high representation of neutralising antibody in the adult community.

Authors:  P J Holmes; J A Hallworth; D I Stocker; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

4.  Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.

Authors:  G R Skinner; C B Woodman; C E Hartley; A Buchan; A Fuller; J Durham; M Synnott; J C Clay; J Melling; C Wiblin; J Wilkins
Journal:  Br J Vener Dis       Date:  1982-12

5.  Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.

Authors:  G R Skinner; C H Hartley; J E Whitney
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

6.  The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.

Authors:  G R Skinner; A Buchan; C E Hartley; S P Turner; D R Williams
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

7.  Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects.

Authors:  G R Skinner; J E Whitney; C Hartley
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

8.  Herpesvirus-specific RNA and protein in carcinoma of the uterine cervix.

Authors:  J K McDougall; C P Crum; C M Fenoglio; L C Goldstein; D A Galloway
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

9.  Neutralising antibody against type 1 and type 2 herpes simplex virus in cervical mucus of women with cervical intra-epithelial neoplasia.

Authors:  J F Murphy; D F Murphy; S Barker; M L Mylotte; B M Coughlan; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

10.  The relative infrequency and low levels of neutralising and immunoprecipitating antibody to herpes simplex viruses types 1 and 2 in patients with a history of recurrent herpes genitalis.

Authors:  C B Woodman; D Stocker; D Sugrue; M Desberbasques; C E Hartley; A Fuller; A Buchan; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.